Expansion into upstream, power generation, transportation infrastructure, pharmaceuticals and healthcare, and O&M
First written in FY2018. 3 of 4 entries say "Advanced", first in FY2020. Latest entry: FY2022.
34 other companies' latest entry also says "Advanced".
- FY2022AdvancedAnnual report
「We plan to generate revenue of ¥50 billion in fiscal 2025 and develop the business into one with revenue of approximately ¥500 billion in 10 years.」
Energy transition, healthcare and life sciences, resource circulation, and industrial and urban infrastructure were identified as future growth engines, with targets of ¥50 billion in fiscal 2025 and approximately ¥500 billion in 10 years. - FY2022-Q2AdvancedAnnual report
「The company also entered into a business transfer agreement for the acquisition of the pharmaceutical manufacturing plant EPC business owned by 株式会社IHIプラント.」
Regarding expansion into pharmaceuticals and healthcare, the signing of a business transfer agreement for the acquisition of IHI Plant’s pharmaceutical manufacturing plant EPC business was formalized. - FY2020AdvancedAnnual report
「After winning an order for the first offshore LNG plant construction project in Africa in the Republic of Mozambique, we established our position as a leading contractor for offshore LNG plant construction by expanding our business into the offshore field.」
Regarding expansion into the offshore field, the company reported the award of the Mozambique project and the establishment of a position in offshore LNG as tangible results. - FY2018First statedAnnual report
「We will seek to expand our business areas by entering the upstream field, strengthening power generation in fossil fuels, nuclear power and renewable energy, expanding into transportation infrastructure, promoting overseas expansion in pharmaceuticals and healthcare, and entering the O&M services business to enhance the business value of plants.」
The company indicated a policy of expanding its business areas beyond oil and gas to upstream, power generation, transportation infrastructure, pharmaceuticals and healthcare, and O&M.